摘要T7 ARCA加帽 mRNA合成試劑盒It produces capped RNA by in vitro transcription using T7 RNA polymerase and the anti-reverse cap analog (ARCA) m2 ...

摘要 cellscript Cap1加帽試劑盒可提供 ScriptCap Capping Enzyme 和 ScriptCap 2'-O-Methyltransferase 兩種酶進行蓋帽過程。

摘要The ScriptCap™ 2'-O-Methyltransferase Kit(Cellscript 2-O-甲基轉移酶試劑盒)prepares cap 1-RNA from any source of cap 0-RNA. In part,cap 1...

摘要ScriptCap™ m7G Capping System(Cellscript m7G加帽試劑盒)catalyzes in vitro addition of a cap nucleotide to the 5' terminus of primary ...

摘要The SP6-Scribe™ Standard RNA IVT Kit(SP6 RNA體外轉錄試劑盒)is specially formulated to enable users to obtain the maximum possible yield...

摘要Cellscript中國代理The T7-Scribe™Standard RNA IVT Kit is specially formulated to enable users to obtain the maximum possible yields o...

摘要The T7-FlashScribe™ Transcription Kit(T7體外轉錄試劑盒)is specially formulated to enable users to obtain the maximum possible yields of...

摘要 Lipofectamine3000脂質體轉染試劑采用脂肪納米微粒技術，實現*轉染性能，具有改善的應用結局和可重現結果。對于多種難轉染和常見的細胞（例如 HEK293、HeLa），該試劑可提供*的轉染效率和改善的細胞活力。

摘要 Lipofectamine2000轉染試劑是一種多功能轉染試劑，研究表明其能有效轉染較廣泛的貼壁和懸浮細胞系。研究人員將該試劑用于基于 siRNA 和 shRNA 的基因敲除實驗以及基因表達研究。

摘要 polyplus RNA脂質體轉染試劑是用于核酸遞送的病毒載體的好的替代品。 它們易于使用、具有成本效益，被認為是安全高效的RNA遞送載體。

摘要 DNA/siRNA轉染試劑是一種功能強大且用途廣泛的 DNA 和 siRNA 轉染試劑，適用于日常實驗，可產生高效可靠的科學結果。

摘要 mRNA轉染試劑與DNA轉染一樣簡單，優點是mRNA無需到達細胞核即可表達，也無需細胞分裂即可高效表達基因。

摘要 Polyplus PEI DNA轉染試劑，是一種線性聚乙烯亞胺衍生物，不含動物源成分，可為貼壁細胞和懸浮細胞提供高效且可重復的基因遞送。

摘要 Polyplus DNA高效轉染試劑,是一種創新的陽離子納米技術，旨在提高用作體外細胞培養模型的易轉和難轉細胞的 DNA 轉染效率。

摘要 polyplus代理，jetOPTIMUS®DNA轉染試劑是一種創新的陽離子納米技術，旨在提高用作體外細胞培養模型的易轉和難轉細胞的 DNA 轉染效率。

摘要 PEI MAX DNA轉染試劑是一種功能強大，值得信賴且經濟實惠的瞬時轉染試劑。

摘要 PEI 25K線性轉染試劑是一種功能強大、值得信賴且具有成本效益的瞬時轉染試劑。

摘要 HEK293細胞轉染試劑，PEI Prime是以一種陽離子高分子聚合物-聚乙烯亞胺(polyethylenimine，PEI)為載體的基因轉染試劑。

摘要 線性化聚乙烯亞胺 PEI轉染試劑，PEI Prime是以一種陽離子高分子聚合物-聚乙烯亞胺(polyethylenimine，PEI)為載體的基因轉染試劑。

摘要 PEI瞬時轉染試劑，PEI Prime是以一種陽離子高分子聚合物-聚乙烯亞胺(polyethylenimine，PEI)為載體的基因轉染試劑。

摘要凡德他尼 VandetanibVandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity...

摘要 索拉非尼 SorafenibSorafenib is a synthetic compound targeting growth signaling and angiogenesis.

摘要帕唑帕尼 PazopanibPazopanib is an approved drug, is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineo...

摘要樂伐替尼 LenvatinibLenvatinib,also known as E7080,is a synthetic,orally available inhibitor of vascular endothelial growth factor receptor...

摘要卡博替尼 CabozantinibCabozantinib, also known as XL-184 or BMS-907351, is an orally bioavailable, small molecule receptor tyrosine kinase ...

摘要 Axitinib, also known as AG013736, is an orally bioavailable tyrosine kinase inhibitor.

摘要 KPT-330 SelinexorSelinexor, also known as KPT-330, is an orally bioavailable, potent and selective XPO1/CRM1 Inhibitor.

摘要格拉吉布 GlasdegibGlasdegib, also known as PF-04449913, is an orally bioavailable small-molecule inhibitor of the Hedgehog (Hh) signaling ...

摘要CAL-101 IdelalisibIdelalisib, also known as CAL-101, is a PI3K-delta inhibitor with potential immunomodulating and antineoplastic acti...

摘要IPI 145 DuvelisibAlso known as IPI-145 and INK-1197, is an orally bioavailable, highly selective and potent small molecule inhibitor o...

摘要 BAY 80-6946 CopanlisibCopanlisib also known as BAY 80-6946, is a potent phosphoinositide 3-kinase (PI3K) inhibitor.

摘要阿培利司 AlpelisibAlpelisib, also known as BLY719, is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential...

摘要BMN 673 TalazoparibTalazoparib, also known as BMN-673 and MDV-3800,is an orally bioavailable inhibitor of the nuclear enzyme poly(ADP-...

摘要魯卡帕尼 RucaparibRucaparib is a tricyclic indole poly(ADP-Ribose) polymerase (PARP1) inhibitor with potential chemosensitizing, radiosens...

摘要尼拉帕尼 NiraparibNiraparib, also known as MK4827, is an orally active, potent and selective poly(ADP-Ribose) polymerase (PARP) inhibitor ...

摘要奧拉帕尼 OlaparibOlaparib, also known as AZD-2281 or KU-59436 , is a small molecule inhibitor of the nuclear enzyme poly(ADP-ribose) polym...

摘要拉羅替尼 LarotrectinibLarotrectinib, also known as ARRY-470 and LOXO-101, is an orally bioavailable, potent, ATP-competitive inhibitor of ...

摘要恩曲替尼 EntrectinibEntrectinib, also known as RXDX-101 and NMS-E628, is an oral small molecule inhibitor of TrkA, TrkB and TrkC, as well ...

摘要 TemsirolimusTemsirolimus is an ester analog of rapamycin. Temsirolimus binds to and inhibits the mammalian target of rapamycin (mTOR),

摘要依維莫司 EverolimusEverolimus, also known as RAD001, is a derivative of the natural macrocyclic lactone sirolimus with immunosuppressant a...

摘要曲美替尼 TrametinibTrametinib, also known as GSK1120212, is a n orally bioavailable inhibitor of mitogen-activated protein kinase kinase (...

摘要考比替尼 CobimetinibCobimetinib, also known as GDC-0973 and XL-518, RG 7420, is an orally bioavailable small-molecule inhibitor of mitogen...

摘要 貝美替尼 BinimetinibBinimetinib, also known as MEK162 (ARRY-162), is an oral, highly selective MEK inhibitor.

摘要艾伏尼布 Ivosidenib Ivosidenib, also known as AG-120 and RG-120, is an orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1...

摘要伊那尼布 EnasidenibEnasidenib, also known as AG-221 and CC-90007, is a potent and selective IDH2 inhibitor with potential anticancer activ...